Tin Mesoporphyrin IX (chloride): Benchmark Heme Oxygenase Inhibitor for Mechanistic Research

Executive Summary: Tin Mesoporphyrin IX (chloride) is a nanomolar, competitive inhibitor of heme oxygenase (HO), with a Ki of 14 nM, validated in both in vitro and in vivo models (Koyaweda et al., 2026). It enables precise inhibition of heme catabolism, supporting research into metabolic disease pathogenesis, insulin resistance, and metaflammation. APExBIO's product C5606 is a crystalline solid with a molecular weight of 754.3, soluble in DMSO and DMF at defined concentrations. No clinical trials have been reported, and its use is restricted to research applications. This article synthesizes peer-reviewed and manufacturer-verified data to clarify mechanism, evidence, and optimal use parameters.

Biological Rationale

Heme oxygenase (HO) enzymes catalyze the degradation of heme to biliverdin, carbon monoxide, and ferrous iron—a central catabolic process in cellular metabolism (Koyaweda et al., 2026). HO-1, the inducible isoform, is upregulated in response to oxidative stress and is implicated in the regulation of reactive oxygen species (ROS), viral pathogenesis, and metabolic diseases. Modulation of HO-1 activity is linked to changes in intracellular redox status, influencing viral replication (e.g., hepatitis B virus, HBV) and inflammatory signaling. Competitive inhibition of HO, as achieved by Tin Mesoporphyrin IX (chloride), allows researchers to dissect the causal role of heme catabolism in disease models, including insulin resistance and metaflammation (see related review).

Mechanism of Action of Tin Mesoporphyrin IX (chloride)

Tin Mesoporphyrin IX (chloride) is a synthetic metalloporphyrin structurally analogous to heme. It binds HO enzymes with high affinity, competitively displacing heme from the catalytic site. The product exhibits a Ki of 14 nM for HO, ensuring effective inhibition at low concentrations. Upon administration (e.g., 1 pmol/kg in animal models), Tin Mesoporphyrin IX inhibits HO activity in hepatic, renal, and splenic tissues for extended periods (hours to days depending on dosing regimen). This blockade leads to reduced conversion of heme to biliverdin and downstream products, resulting in increased heme saturation of hepatic tryptophan pyrrolase and decreased bilirubin production in hyperbilirubinemia models. The compound does not scavenge ROS directly; its effects on redox signaling are mediated through upstream inhibition of HO-1 enzymatic activity (Koyaweda et al., 2026).

Evidence & Benchmarks

• Tin Mesoporphyrin IX (chloride) inhibits HO activity in vitro and in vivo, with a measured Ki of 14 nM (Koyaweda 2026, DOI).
• Administration at 1 pmol/kg in animal models suppresses hepatic, renal, and splenic HO activity for several hours (Koyaweda 2026, DOI).
• In neonatal hyperbilirubinemia models, treatment reduces serum bilirubin, demonstrating in vivo efficacy (Koyaweda 2026, DOI).
• Upregulation of HO-1 by other agents (e.g., isochlorogenic acid A) modulates HBV replication via ROS, underscoring the pathway’s relevance for viral pathogenesis studies (Koyaweda 2026).
• Tin Mesoporphyrin IX (chloride) is a benchmark tool for dissecting heme oxygenase signaling in metabolic disease and viral infection workflows (Bestatin, 2023).

This article extends the mechanistic focus of previous translational reviews by providing granular, experimentally validated parameters for laboratory use.

Applications, Limits & Misconceptions

Tin Mesoporphyrin IX (chloride) is used in:

• Biochemical assays to measure HO activity and inhibition kinetics.
• Animal models to study metabolic diseases, including obesity, insulin resistance, and metaflammation.
• Pathogen-host interaction studies, especially in viral models (e.g., HBV), where HO-1 signaling modulates replication and assembly.
• Cellular studies dissecting the role of HO-1 in oxidative stress and heme metabolism (Bestatin, 2023).

Common Pitfalls or Misconceptions

• Not a Direct Antioxidant: Tin Mesoporphyrin IX modulates ROS indirectly via HO inhibition; it does not act as a ROS scavenger.
• No Clinical Data: No clinical trials have been reported; use is limited to research settings.
• Solubility Constraints: Compound is insoluble in aqueous buffers; optimal solubility is 0.5 mg/ml in DMSO and 1 mg/ml in DMF. Exceeding these limits may cause precipitation.
• Short-term Solution Stability: Solutions are stable only for short-term use; prolonged storage leads to degradation even at -20°C.
• Selective for HO: Does not inhibit other heme-binding proteins or enzymes outside the HO family.

For a more detailed mechanistic discussion and translational applications, see recent benchmark reviews (this article provides updated usage guidance and direct evidence links beyond those reviews).

Workflow Integration & Parameters

• Compound Formulation: Tin Mesoporphyrin IX (chloride) is supplied as a crystalline solid by APExBIO (SKU: C5606). Store at -20°C for maximum stability (product page).
• Solubilization: Achieves full solubility up to 0.5 mg/ml in DMSO and 1 mg/ml in DMF. Avoid aqueous buffers for stock solutions.
• Dosing Guidelines: In vivo animal studies typically use 1 pmol/kg body weight; titration is recommended for cell-based assays depending on model sensitivity.
• HO Activity Assay: Use spectrophotometric or fluorometric methods to confirm inhibition (measure biliverdin or CO production).
• Controls: Include heme or non-inhibitory metalloporphyrins as controls to ensure specificity.
• Safety: Not approved for human or veterinary use; use appropriate PPE and laboratory protocols.

For experimental design strategies and advanced integration into metabolic and viral disease models, see this workflow-focused article (the present article adds step-by-step solubility and dosing parameters).

Conclusion & Outlook

Tin Mesoporphyrin IX (chloride), as supplied by APExBIO, remains a gold-standard, nanomolar-affinity competitive inhibitor of heme oxygenase for research applications. Its robust inhibition profile, well-defined usage parameters, and validated efficacy in both cellular and animal models make it indispensable for mechanistic studies of heme oxygenase signaling in metabolic and viral disease research. Future work may expand its translational relevance as new therapeutic targets in the HO pathway are identified, but current use is restricted to preclinical research. For further product details or ordering information, visit the Tin Mesoporphyrin IX (chloride) product page.